Medistep Healthcare (NSE:MEDISTEP) EV-to-EBITDA: (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDISTEP Medistep Healthcare Ltd NSE:MEDISTEP
23 GF Score
Price ₹22.50
! 3 Warning Signs
View Full Analysis

What is Medistep Healthcare EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Medistep Healthcare's enterprise value is ₹365.4 Mil. Medistep Healthcare does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Medistep Healthcare's EV-to-EBITDA at this moment.

The historical rank and industry rank for Medistep Healthcare's EV-to-EBITDA or its related term are showing as below:

NSE:MEDISTEP' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.25   Med: 5.46   Max: 10.29
Current: 4.47

During the past 5 years, the highest EV-to-EBITDA of Medistep Healthcare was 10.29. The lowest was 3.25. And the median was 5.46.

NSE:MEDISTEP's EV-to-EBITDA is ranked better than
79.21% of 101 companies
in the Medical Distribution industry
Industry Median: 8.43 vs NSE:MEDISTEP: 4.47

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-09-16), Medistep Healthcare's stock price is ₹22.50. Medistep Healthcare does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026. Therefore, GuruFocus does not calculate Medistep Healthcare's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Medistep Healthcare  (NSE:MEDISTEP) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medistep Healthcare's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=22.50/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Medistep Healthcare EV-to-EBITDA Related Terms

Medistep Healthcare EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Medistep Healthcare's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medistep Healthcare EV-to-EBITDA Chart

Medistep Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-EBITDA
0.00 0.00 0.00 0.00 0.00

Medistep Healthcare Quarterly Data
Sep25 Mar26
EV-to-EBITDA 0.00 0.00

NSE:MEDISTEP vs MCK, COR, CAH: EV-to-EBITDA Comparison

For the Medical Distribution subindustry, Medistep Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medistep Healthcare EV-to-EBITDA vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medistep Healthcare's EV-to-EBITDA falls into.


NSE:MEDISTEP
23GF Score
Medistep Healthcare Ltd NSE:MEDISTEP
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medistep Healthcare EV-to-EBITDA Calculation

Medistep Healthcare's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=365.398/
=

Medistep Healthcare Business Description

Address National Highway 8, 05, S. No-245/B, Plot-19, T.P.S. 56, Free Way Trade Center, Near A-One Hotel, Narol Gam, Narol, Daskroi, Ahmadabad, GJ, IND, 382405
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
23GF Score

Get the complete analysis for NSE:MEDISTEP

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹22.50
Price